Table 3

Comparison between 2001 and 2011 survey of ever having a diagnosis of genital warts or chlamydia in all women and stratified by age groups based on respectively eligibility for the Australian HPV vaccination programme and chlamydia population screening recommendations

CasesPopulationUnweighted age-adjusted ORUnweighted fully adjusted OR*Weighted age-adjusted ORWeighted fully adjusted OR*
Past warts diagnosis reported
All women
 2001 survey25348621.001.001.001.00
 2011 survey8823630.90 (0.70–1.17)0.90 (0.69–1.17)1.14 (0.81–1.59)1.10 (0.78–1.54)
18–30 years (eligible HPV vaccine programme)
 2001 survey10123851.001.001.001.00
 2011 survey4518450.59 (0.41–0.850.61 (0.42–0.88)0.63 (0.43–0.93)0.59 (0.39–0.89)
31–39 years (Ineligible HPV vaccine programme)
 2001 survey15224771.001.001.001.00
 2011 survey435181.38 (0.97–1.96)1.37 (0.95–1.96)1.67 (1.08–2.58)1.64 (1.05–2.54)
Past chlamydia diagnosis reported
All women
 2001 survey19248571.001.001.001.00
 2011 survey12723731.47 (1.16–1.87)1.53 (1.19–1.95)1.44 (1.09–1.90)1.41 (1.07–1.87)
18–24 years (target chlamydia screening)
 2001 survey2810731.001.001.001.00
 2011 survey469281.95 (1.21–3.15)2.07 (1.26–3.39)1.84 (1.08–3.15)1.97 (1.15–3.37)
25–39 years (not target chlamydia screening)
 2001 survey16437841.001.001.001.00
 2011 survey8114451.29 (0.97–1.71)1.34 (1.01–1.80)1.32 (0.95–1.83)1.30 (0.93–1.82)
  • Analyses exclude those with unknown genital warts or chlamydia status.

  • See methods for full details of how weights were estimated.

  • Analyses for warts adjusted for chlamydia and vice versa.

  • *Adjusted for age, country of birth, state of residence, education, aboriginality.

  • HPV, human papillomavirus.